This educational activity will review clinical data on an emerging treatment for blepharoptosis to help eyecare practitioners better identify, diagnose and treat appropriate patients who would benefit from pharmacologic treatment of blepharoptosis.

This educational activity is intended to provide a real-world perspective on new treatment approaches being used to address the underlying pathophysiology of neovascular age-related macular degeneration and diabetic macular edema.

This is a 4-part series of 15-minute discussions that will help optometrists who care for patients with neovascular age-related macular degeneration and diabetic macular edema better understand how to address the burden patients face, current treatment options, the need for longer-acting treatments, and best practices.

In this interprofessional webcast, experts in optometric and neurologic assessment and treatment of neuromyelitis spectrum disorder (NMOSD) discuss best practices in diagnosis and referral of patients with possible NMOSD as well as clinical data supporting 3 newly approved long-term suppressive treatments specifically targeting immunologic pathways altered by NMOSD autoantibodies.